The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if you read kind of the fine print it does not appear it was halted for a bad reason meaning it might have been halted actually for basically early efficacy which presumably would have been in the group getting the methotrexate
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and then there was also a trial that looked at using low dose of methotrexate you still ongoing there was a some preliminary words that of that this is looking good but it's not been definitively but there is the theory to say reduce inflammation and you will certainly help vascular health in capacities maybe even I have nothing to do with lipids or so